Nitric oxide in immunity and inflammation

被引:723
作者
Coleman, JW [1 ]
机构
[1] Univ Liverpool, Dept Pharmacol, Liverpool L69 3GE, Merseyside, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
nitric oxides; inflammatory cells; immunity;
D O I
10.1016/S1567-5769(01)00086-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nitric oxide (NO) is synthesised by many cell types involved in immunity and inflammation. The principal enzyme involved is the inducible type-2 isoform of nitric oxide synthase (NOS-2), which produces high-level sustained NO synthesis. NO is important as a toxic defense molecule against infectious organisms. It also regulates the functional activity, growth and death of many immune and inflammatory cell types including macrophages, T lymphocytes, antigen-presenting cells, mast cells, neutrophils and natural killer cells. However, the role of NO in nonspecific and specific immunity in vivo and in immunologically mediated diseases and inflammation is poorly understood. NO does not act through a receptor-its target cell specificity depends on its concentration, its chemical reactivity, the vicinity of target cells and the way that target cells are programmed to respond. At high concentrations as generated by NOS-2, NO is rapidly oxidised to reactive nitrogen oxide species (RNOS) that mediate most of the immunological effects of NOS-2-derived NO. RNOS can S-nitrosate thiols to modify key signalling molecules such as kinases and transcription factors. Several key enzymes in mitochondrial respiration are also inhibited by RNOS and this leads to a depletion of ATP and cellular energy. A combination of these interactions may explain the multiple actions of NO in the regulation of immune and inflammatory cells. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1397 / 1406
页数:10
相关论文
共 61 条
[1]   The physiological role and pharmacological potential of nitric oxide in neutrophil activation [J].
Armstrong, R .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) :1501-1512
[2]   NITRIC-OXIDE AND ASTHMATIC INFLAMMATION [J].
BARNES, PJ ;
LIEW, FY .
IMMUNOLOGY TODAY, 1995, 16 (03) :128-130
[3]   NO or no NO in asthma? [J].
Barnes, PJ .
THORAX, 1996, 51 (02) :218-220
[4]   Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells [J].
Bauer, H ;
Jung, T ;
Tsikas, D ;
Stichtenoth, DO ;
Frolich, JC ;
Neumann, C .
IMMUNOLOGY, 1997, 90 (02) :205-211
[5]   NITRIC-OXIDE IS THE ENDOGENOUS NEUROTRANSMITTER OF BRONCHODILATOR NERVES IN HUMANS [J].
BELVISI, MG ;
STRETTON, CD ;
YACOUB, M ;
BARNES, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (02) :221-222
[6]   Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression:: Inhibition of IL-2 gene expression in murine lymphocytes [J].
Berendji, D ;
Kolb-Bachofen, V ;
Zipfel, PF ;
Skerka, C ;
Carlberg, C ;
Kröncke, KD .
MOLECULAR MEDICINE, 1999, 5 (11) :721-730
[7]   Mast cells as a source and target for nitric oxide [J].
Bidri, M ;
Féger, F ;
Varadaradjalou, S ;
Ben Hamouda, N ;
Guillosson, JJ ;
Arock, M .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) :1543-1558
[8]   Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity [J].
Bogdan, C ;
Röllinghoff, M ;
Diefenbach, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :64-76
[9]   Nitric oxide and mitochondrial respiration [J].
Brown, GC .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :351-369
[10]   Nitric oxide in parasitic infections [J].
Brunet, LR .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) :1457-1467